Institut Régional du Cancer de Montpellier   Report issue

Academic/Hospital Phase 2
Founded: Montpellier France (1923)

Organization Overview

First Clinical Trial
2019
NCT04053322
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

INSTITUT DE CANCEROLOGIE DE MONTPELLIER | Institut de Cancérologie de Montpellier (ICM) | Institut Régional du Cancer de Montpellier

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 6